2.49
2.49 (0%)
As of Feb 07, 2025
Aclaris Therapeutics Inc [ACRS]
Source:
Company Overview
Aclaris Therapeutics, Inc is a clinical-stage biopharmaceutical company focused on developing novel small and large molecule product candidates for immuno-inflammatory diseases.
| Country | United States |
| Headquarters | wayne, pennsylvania |
| Phone Number | (484) 324-7933 |
| Industry | manufacturing |
| CEO | Neal Walker |
| Website | www.aclaristx.com |
Financial Year:
Financial Overview (Dollars in Millions)
| Revenue | $18.7 |
| Operating Profit | $-141.9 |
| Net Income | $-132.1 |
| Net Cash | $-15.3 |
Profit Ratios
| Gross Margin | $15.9 |
| Operating Margin | -758.2 |
| Profit as % of Revenues | -12.1% |
| Profit as % of Assets | -63.2% |
| Profit as % of Stockholder Equity | -84.9% |
Management Effectiveness
| Return on Equity | -84.9% |
| Return on Assets | -59.9% |
| Turnover Ratio | 9% |
| EBITA | $-141.9 |
Balance Sheet and Cash Flow Measures
| Total Assets | $220.3 |
| Total Liabilities | $64.8 |
| Operating Cash Flow | $-20.1 |
| Investing Cash Flow | $-69.8 |
| Financing Cash Flow | $74.5 |
